Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$350.74 - $468.98 $181,332 - $242,462
-517 Reduced 33.42%
1,030 $483,000
Q1 2023

May 12, 2023

SELL
$310.63 - $364.82 $21,433 - $25,172
-69 Reduced 4.27%
1,547 $531,000
Q4 2022

Feb 13, 2023

SELL
$321.55 - $374.67 $1.11 Million - $1.29 Million
-3,447 Reduced 68.08%
1,616 $591,000
Q3 2022

Nov 02, 2022

BUY
$296.48 - $337.87 $1.01 Million - $1.15 Million
3,415 Added 207.22%
5,063 $1.64 Million
Q2 2022

Aug 02, 2022

BUY
$278.73 - $327.27 $368,759 - $432,978
1,323 Added 407.08%
1,648 $534,000
Q1 2022

May 11, 2022

SELL
$234.69 - $291.66 $1.47 Million - $1.83 Million
-6,258 Reduced 95.06%
325 $93,000
Q4 2021

Jan 18, 2022

SELL
$224.85 - $279.04 $1.6 Million - $1.99 Million
-7,121 Reduced 51.96%
6,583 $1.82 Million
Q3 2021

Oct 20, 2021

BUY
$221.6 - $272.71 $2.24 Million - $2.76 Million
10,110 Added 281.3%
13,704 $3.17 Million
Q2 2021

Jul 19, 2021

SELL
$180.55 - $233.54 $2.13 Million - $2.76 Million
-11,806 Reduced 76.66%
3,594 $825,000
Q3 2020

Oct 19, 2020

BUY
$146.22 - $169.13 $1.86 Million - $2.15 Million
12,695 Added 469.32%
15,400 $2.28 Million
Q2 2020

Aug 06, 2020

BUY
$136.42 - $164.18 $14,324 - $17,238
105 Added 4.04%
2,705 $444,000
Q1 2020

Apr 28, 2020

SELL
$119.05 - $147.35 $630,965 - $780,955
-5,300 Reduced 67.09%
2,600 $361,000
Q4 2018

Jan 23, 2019

BUY
$105.9 - $118.64 $836,610 - $937,256
7,900 New
7,900 $914,000
Q1 2018

May 01, 2018

SELL
$74.21 - $87.6 $281,998 - $332,880
-3,800 Closed
0 $0
Q4 2017

Feb 01, 2018

SELL
$81.94 - $87.89 $122,910 - $131,835
-1,500 Reduced 28.3%
3,800 $321,000
Q3 2017

Oct 30, 2017

BUY
$77.07 - $85.54 $408,470 - $453,362
5,300
5,300 $453,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $749B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Clear Street Markets LLC Portfolio

Follow Clear Street Markets LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clear Street Markets LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clear Street Markets LLC with notifications on news.